SBRT Shows Favorable Long-Term Outcomes and Low Severe Toxicity in Studies

SBRT Shows Favorable Long-Term Outcomes and Low Severe Toxicity in Studies
Stereotactic body radiotherapy (SBRT) has shown good long-term outcomes and low rates of severe toxicity, making it a valid treatment option for men with low- and intermediate-risk prostate cancer, according to three studies recently presented at the 36th European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting. All three studies explored the long-term safety and efficacy of the advanced

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

3 comments

  1. Lawrence Glickman says:

    I appreciate your summary but it is at odds the Cyber Knife published results. The “Steady Decline in Sexual Activity” needs to be explained by you in detail since it is of major importance to men. In Accuray’s summaries the results and side effects are the most impressive I’ve seen for PSA reduction and maintenance fast recovery and low side effects. Brachy seeds had higher sexual and rectal side effects over time.
    https://prostatecancernewstoday.com/2017/03/03/cyberknife-system-provides-long-term-disease-control-for-prostate-cancer-patients/

    • Magdalena Kegel says:

      Dear Lawrence,

      Thank you for raising this important question.

      I am, however, not the author of the research, I am merely reporting on what these researchers presented at a scientific meeting, and the team did not offer an explanation. When they do publish one, we will be sure to cover it.

      Medical research studies often come to different conclusions, depending on the group studied and the design of a study.

  2. Lawrence Glickman says:

    Thank you for your open mind and desire to cover the facts. Below is a quote from the Anova Cancer Care Center Doctor in Lone Tree Colorado a major player with Cyber Knife. (Note: I have no relationship with the Cyber Knife company)

    “I’ve personally treated more than 1,100 patients with the CyberKnife for prostate cancer and this is what I have seen:

    Patients with the earliest stage and grade of disease experience zero failures and have 100 percent control of their prostate cancer. In the next highest grade, patients enjoy over 99 percent control of the disease. All of the patients I’ve treated over the last year, regardless of stage and grade of prostate cancer, have had zero delayed side effects.

Leave a Comment

Your email address will not be published. Required fields are marked *